Monday 13 September - Conference Day One
| 08.00 | Registration |
| | Morning Session Chair:
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
, Scientific Update, UK
|
| 08.55 | Opening Remarks
|
| 09.00 | Dr Yi-Yin Ku, Abbott Laboratories, USA Development of a Scalable Process for an Abbott’s HCV Polymerase Inhibitor |
| 09.45 | Dr Christian Chapuis, Firmenich SA, Switzerland The Four Diastereoisomers of Polysantol® and Firsantol® as Probes for a Sandalwood-like Structure Odour Relationship Model |
| 10.30 | Coffee and Exhibition
|
| 11.15 | Dr Greg Gordon, CSIR Biosciences, South Africa Development of a Chemo-Enzymatic Process to β-thymidine: a Process Chemist’s Perspective |
| 12.00 | Dr Dave Ager, DSM Research, USA Green Peptide Synthesis |
| 12.45 | Lunch and Exhibition
|
| | Afternoon Session Chair: Dr Ian Lennon, Chiral Quest
|
| 14.00 | Dr Johan Wennerberg, DuPont Chemoswed, Sweden Anthranilic Acids: Building Blocks for Pharmaceuticals and New Methods for their Syntheses |
| 14.45 | Dr Gwydion Churchill, AstraZeneca, UK AZD8055: Reaping the Benefits of New Route Development |
| 15.30 | Coffee and Exhibition |
| 16.15 | Dr Stefan Abele, Acetelion Pharmaceuticals Ltd, Switzerland Almorexant: Racemate Resolution and Asymmetric Hydrogenation Approaches to the Chiral Tetrahydroisoquinoline. Evolution of the Manufacturing Process |
| 17.00 | Dr Christopher Nichols, GlaxoSmithKline, UK The Rapid Development of an Atom-Efficient Synthesis of a Novel GPCR Agonist |
17.45
| End of Day One |
| 17.45 | Welcome Reception - kindly sponsored by Evonik Industries
|